Workflow
SuRo Capital(SSSS) - 2024 Q4 - Annual Results
SSSSSuRo Capital(SSSS)2025-03-11 21:32

Financial Performance - As of December 31, 2024, SuRo Capital's net asset value is estimated to be between 6.50and6.50 and 7.00 per share, compared to approximately 7.99pershareatDecember31,2023[13].TheCompanyrealizedanetgainof7.99 per share at December 31, 2023[13]. - The Company realized a net gain of 4.8 million from the sale of 239,300 shares of Oklo, Inc. at an average share price of 21.14[17].SuRoCapitalreceived21.14[17]. - SuRo Capital received 5.3 million from the sale of 1,616,187 public common shares of PSQ Holdings, Inc. at an average share price of 3.28[17].TheCompanyexpectstoannounceitsfourthquarterandfiscalyearresultsinMarch2025[20].Thepreliminaryfinancialestimatesprovidedareunauditedandactualresultsmaydiffermaterially[19].InvestmentActivitiesTheCompanyheldpositionsin37portfoliocompaniesasofDecember31,2024,including33privatelyheldand4publiclyheld[15].DuringQ42024,SuRoCapitalinvested3.28[17]. - The Company expects to announce its fourth quarter and fiscal year results in March 2025[20]. - The preliminary financial estimates provided are unaudited and actual results may differ materially[19]. Investment Activities - The Company held positions in 37 portfolio companies as of December 31, 2024, including 33 privately held and 4 publicly held[15]. - During Q4 2024, SuRo Capital invested 5.0 million in CoreWeave, Inc. and 12.0millioninIH10,LLC[16].DebtandFinancingTheoutstandingaggregateprincipalamountoftheCompanysConvertibleNotesisnow12.0 million in IH10, LLC[16]. Debt and Financing - The outstanding aggregate principal amount of the Company's Convertible Notes is now 35.0 million following the issuance of an additional $5.0 million in Convertible Notes[8]. - Interest on the Convertible Notes is paid quarterly at a rate of 6.50% per year, with maturity on August 14, 2029[9]. - The net proceeds from the offering of the New Convertible Notes will be used for repaying outstanding indebtedness and making investments[10].